2020 Practice Group of the Year: Class Action
"Kirkland & Ellis LLP successfully defended AbbVie from a novel theory that it had created a “patent thicket” around its immunosuppressant drug Humira to block cheaper biosimilars from coming onto the market, earning the firm a spot as one of Law360’s Class Action Groups of the Year."
Partners Daniel Donovan and Diana Watral discussed the significance of Kirkland's recent successes for marquee clients in high-stakes class action matters.
